Griscelli syndrome (GS) was diagnosed in a 2-year old patient with oculocutaneous albinism and immunodeficiency, but sequencing of RAB27a only revealed a heterozygous mutation. Due to impaired NK and T cell cytotoxicity implying a high risk of developing
Introduction
Secretory lysosomes are cellular organelles involved in trafficking and exocytosis of intracellular proteins 1 . They have important functions in several cell types including melanocytes, neuronal cells, platelets, granulocytes, mast cells, NK cells and T cells 2 . The protein machinery required for adequate biogenesis, transport and delivery of secretory lysosomes has a variable composition in each cell type. Therefore, the clinical phenotype of diseases due to genetic defects in proteins involved in lysosomal trafficking varies widely despite the similar cell biological basis. This has led to their classification as predominantly dermatologic, hematologic, hemostaseologic or immunologic disorders.
While the 7 genetically defined Hermansky-Pudlak syndromes (HPS) predominantly present as bleeding disorders 3 , the most important clinical problem of patients with Chediak-Higashi syndrome (CHS) and Griscelli syndrome (GS) type II is immunodeficiency 4 . Neurological defects characterize GS type I and CHS 5 , while patients with GS type III only show oculocutaneous albinism 6 . This latter feature links all of these syndromes. However, studies showing that also some forms of familial hemophagocytic lymphohistiocytosis (FHL) represent lysosomal trafficking disorders 7, 8 revealed that albinism is not a constant feature in this heterogenous family of diseases.
Lysosomal trafficking disorders associated with immunodeficiency are life-threatenting conditions due to the high risk of developing hemophagocytic lymphohistiocytosis (HLH) 4 . HLH is a systemic inflammatory disorder characterized by uncontrolled CD8+ T cell and macrophage activation with infiltration of multiple tissues 9 . The common defect in most genetic diseases predisposing to HLH is disturbed secretion of lytic granules by cytotoxic
For personal use only. on . by guest www.bloodjournal.org From T cells (CTL) and NK cells 2 . Regulated secretion of these granules containing the poreforming protein perforin is required for CTL and NK cell mediated cytotoxicity. Current models suggest that in the context of antimicrobial immune responses, cytotoxicity is not only required to kill infected cells, but also to kill antigen-presenting cells thereby limiting T cell stimulation 10 . A lack of this negative regulation leads to continued T cell activation with excessive cytokine production and subsequent macrophage activation 10 . Patients with genetic deficiency in perforin 11 or in genes absolutely required for lytic granule secretion such as MUNC 13-4 8 , develop HLH within the first year of life unless treated by hematopoetic stem cell transplantation (HSCT). In patients with GS II and CHS the defect in granule mobilization is less severe and HLH usually develops later in life, but GS II is also invariably fatal unless HSCT is performed 12 .
Recently, disturbed secretion of lytic granules by CTL has also been described in a patient with HPS type II 13 , which is caused by mutations in the gene encoding the β-subunit of the cytosolic adaptor protein AP-3 (AP-3β1) 14 . The clinical presentation of HPS II has so far only been described in 3 patients and included oculocutaneous albinism, bleeding, recurrent infection and neutropenia 15, 16 . Mild facial dysmorphia, hepatosplenomegaly, developmental delay and pulmonary fibrosis have also been reported in one patient 16 , but the few reported cases so far preclude a complete definition of the syndrome. Importantly, the clinical consequences of the cytotoxicity defect, in particular the risk of developing HLH, remain unclear. In this report, we present a new patient with HPSII. He is the first patient who developed HLH, indicating that HPSII belongs to the group of familial hemophagocytic syndromes and may represent an indication for HSCT.
For
Study design

Informed consent
Informed consent for the performed studies and publication of photographs was obtained from the patient's family in accordance with the guidelines of the local ethics committee.
Patient
The patient is the third child of healthy first degree cousins. Both parents and the two older siblings are healthy and an extended family history did not reveal the presence of albinism, developmental delay, bleeding or increased susceptibility to infection. He had connatal nystagmus, blue eyes, bright skin colour, silvery-blond hair (Fig. 1A,B ) and mild facial dysplasia including a broad coarse face, a broad nasal root, mild epicanthal folds, a long philtrum and low-set posteriorly rotated ears (Fig. 1A,B) . He had normal skeletal growth, but flat dysplastic acetabulae (Fig. 1C) . At the age of 2 years, neurophysiological development was delayed by 8-10 months. An MRI of the brain was normal. Moderate hepatosplenomegaly without signs of liver dysfunction was first noted at the age of 3 months. Neutropenia (800/μl) was documented at 8 months of age and subsequently fluctuated. From the age of 6 months, he suffered from more than 10 episodes of otitis media, 3 pneumonias and recurrent oral thrush. He had self-limiting perinatal CMV infection and MMR live vaccine was well tolerated. No bleeding tendency was reported.
Cytotoxicity assays and flow cytometry
For NK cell assays, 51 Cr labelled K562 targets were incubated with PBMC effectors directly after Ficoll isolation or after 7 days stimulation with 100 U/ml IL-2 (Chiron, 
Platelet studies
Blood was taken into 3.8% sodium citrate. PRP was prepared by centrifugation at 80g for 10 min, incubated with 50 μM mepacrine (DL Quinacrine, Kand K labs, Plain New, New York) at 37°C for 30 min and then centrifuged at 1000g for 10 min in the presence of ACD-A (1vol/9vol). The platelets resuspended in PBS were examined either by fluorescence microscopy using the Axiapla 2 Imaging microscope coupled with Isis software (Zeiss, Le Pecq, France) or by flow cytometry using the Cytomics FC 500 flow cytometer equipped with CXP software (Beckman-Coulter, Villepinte, France). 18 . For whole mounts electron microscopy, blood was taken into ACD-A. The platelets were washed as described previously and incubated with 2 mM Ca ++ for 30 min at room temperature. They were then fixed in 2% (vol/vol) paraformaldehyde (PFA), and a drop was deposited onto collodion-coated nickel grids. They were rinsed twice with PBS and once with distilled water. The samples were then examined with a Jeol JEM-1010 electron 
Genetic analysis
Genomic DNA was used to sequence all exons of RAB27A and AP3B1. Primers are available on request (klaus.schwarz@medizin.uni-ulm.de).
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Results
Lack of NK cell cytotoxicity partially restored by IL-2 stimulation
The combination of oculocutaneous albinism (Fig. 1A,B) and increased susceptibility to infection suggested a genetic disorder of lysosomal trafficking. Absence of an obvious bleeding tendency and of giant granules in neutrophils excluded CHS. Hair shaft analysis revealed small clusters of pigment unevenly distributed throughout the hair shaft (Fig. 1D) .
Although lacking the typical large pigmented granules (12) , this morphology was interpreted to be compatible with GSII. NK cell function was studied for further confirmation of this diagnosis. The patient had normal numbers of NK cells, but completely lacked ex vivo cytolytic activity against NK sensitive K562 target cells ( Fig.   2A ). This was observed in 4 independent experiments, one of which included 2 control patients with HPS of so far unknown genetic cause. IL-2 stimulation for 7 days partially restored cytolytic activity against K562 targets ( Fig. 2B ) and against the allogeneic EBV transformed B cell line 711 (data not shown), indicating that the defect in cytotoxicity was not absolute.
Impaired CTL mediated cytotoxicity and reduced CTL degranulation
Perforin-mediated CTL activity was studied in an anti-CD3 redirected lysis assay using CD95 negative L1210 targets. The patient had a normal number of CD8+ T cells with normal intracellular expression of perforin (data not shown). However, lytic activity of d7 PHA blasts was significantly reduced (Fig. 3) . Expression of the lysosomal marker protein CD107 on activated CTL has recently been found to indicate degranulation and to correlate with lytic activity 17 . Interestingly, expression of CD107 and CD63 on unstimulated CTL
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From was higher in the patient than in controls (Fig. 4A,B) . By contrast, anti-CD3/anti-C28 stimulation induced significant CD107 expression in short-term PHA blasts from controls, but not from the patient (Fig. 4C ). An independent analysis of 2 patients with genetically ascertained GS II or CHS confirmed the validity of this assay (Fig. 4C, D) . The observed defect in NK and CTL cytotoxicity was consistent with the diagnosis of GS II. Sequencing of the RAB27A gene revealed a paternally inherited mutation (Del381, 382AG, Ins381C) leading to a Stop codon at AS 84 (Fig. 8A,B) . Both truncated and wild-type RNA were present. Although the diagnosis of GSII could not be molecularly ascertained, an unrelated donor search for HSCT was initiated due to the potential risk of developing HLH.
Abnormal number, size and distribution of dense granules associated with impaired platelet aggregation
Unexpectedly, the patient developed severe bleeding after a tooth extraction in preparation for HSCT. PT, aPTT and platelets were normal, but the bleeding time was prolonged (15 minutes). Analysis of platelet function revealed almost no platelet aggregation after stimulation with epinephrine, collagen and arachidonic acid. Aggregation after ADP stimulation (2 μmol/l) was severely reduced (22% maximum response; Fig. 5A ), while ristocetin (1.6 mg/ml) induced a normal maximal response with early disaggregation. Platelet degranulation was quantified by measuring expression of the lysosomal marker protein CD63 in response to thrombin stimulation. Similar to the CTL studies, CD63 expression was already increased on resting platelets, but there was only little increase after thrombin stimulation (Fig. 5B) . By contrast, expression of CD62, which is upregulated independently of secretory lysosomes, was similar in the patient and a control subject both at baseline and after stimulation (Fig. 5C) .
Characterization of the platelets was extended to mepacrine staining and whole mount
microscopy. When mepacrine-loaded platelets were observed by fluorescence microscopy, fewer dense bodies were seen in the patient compared to healthy controls.
Those that were present were often of increased size ( Fig 6A,B control ; C,D patient) and did not flash normally. Yet, when identical samples were analysed by flow cytometry, the fluorescence histograms were similar for patient and control suggesting that overall mepacrine uptake by the platelets was similar (Fig 6E) . Analysis of PFA-fixed platelets loaded with calcium by electron microscopy showed a large reduction in the number of dense granules (mean numbers of 1 per patient platelet versus 3.55 per control platelet; n = 100 platelets) (Fig. 6F-H) . Nevertheless, granules were present in 41% of the patient's platelets. Significantly, many of the residual dense bodies were of abnormal shape and of increased size as illustrated in Fig 6C,D and H. 
G-CSF responsive neutropenia due to an incomplete maturational arrest in the bone marrow
The neutropenia was initially thought to be transient and caused by infections, but an absolute neutrophil count (ANC) persistently below 1000/μl prompted further investigations. A bone marrow aspirate revealed an incomplete maturation arrest of the myeloid lineage at the stage of promyelocytes and myelocytes. Among the few cells that matured beyond that stage, there was moderate granulocytic dysplasia ( Fig. 7A-C) . There was a good response to G-CSF therapy and stable ANC's above 1500/μl were obtained with 7.5 μg/kg/d (Fig. 7D) .
A novel homozygous mutation in the AP3B1 gene
In the context of neutropenia and bleeding, HPSII was suspected and the AP3B1 gene was sequenced. The patient is homozygous for a novel mutation (A1029T) (Fig. 8A-C) . Both parents are heterozygous for the mutation (Fig. 8B) . The father is also heterozygous for the RAB27a mutation (Fig. 8A,B) , but does not show clinical signs and was normal in all functional CTL and platelet assays.
Development of lethal hemophagocytic syndrome
None of the three published HPS II patients aged 7, 20 and 25 years ( 14 and CTL clones 13 . In this study, we demonstrate increased baseline expression of CD63 also on resting platelets and of CD63 and CD107 on resting CTL.
However, in contrast to platelets and CTL from healthy controls, activation did not further increase surface expression of these proteins. This correlates with previously demonstrated impaired secretion of platelet dense granules 28 and lytic granules 13 leading to severe impairment of platelet aggregation and of lytic CTL and NK cell activity. Our findings indicate that studies of expression of these lysosomal proteins on the surface of resting and activated cells will be useful for the diagnosis of HPSII. The CD107 CTL degranulation assay 17 will also be a useful adjunct for the detection of degranulation defects in the differential diagnosis of HLH 29 .
Two additional cell biological consequences of AP3 deficiency are disturbed vesicle biogenesis and impaired polarization of secretory lysosomes 13, 30 . It is plausible to assume that these features are due to missorting of structural components of lysosomes and/or of proteins required for lysosomal polarization 1 , but this remains to be proven. Malformed and enlarged secretory lysosomes have been demonstrated in AP-3 deficient mouse melanocytes 30 and platelets 28 and in human CTL clones 13 . We show that human AP-3 deficient platelets show a characteristic pattern in size and distribution of dense bodies. Of note, in contrast to most other variants of HPS 31 , dense bodies are reduced, but present and overall mepacrine uptake is similar. Furthermore, from a clinical perspective, the bleeding disorder in our and the previously reported patients 15, 16 was mild and did not dominate the initial clinical presentation. We therefore suggest that a bleeding time should be performed in any patient presenting with albinism and immunodeficiency.
HPS II is distinguished from the other forms of HPS by an increased susceptibility to
infections. There are various factors that may contribute to the immunodeficiency of AP-3 deficient patients. First, the degranulation defect of CTL and NK cells impairs lysis of infected target cells 13 . Second, presentation of lipid antigens from bacteria is reduced due to less efficient sorting of CD1b to the lysosome 32 . Third, all reported patients had severe neutropenia 15, 16 . Since G-CSF therapy controlled the increased incidence of infections in our and in one previously reported patient 16 , it appears that neutropenia and not impaired antigen presentation, the cytotoxicity defect or other unidentified factors mainly determine the increased susceptibility to infection in these patients.
A key clinical question is whether the cytotoxicity defect in HPSII predisposes to HLH and therefore represents an indication for preemptive bone marrow transplantation. AP-3 deficiency causes loss of microtubule-mediated movement of lytic granules toward the immunological synapse in NK cells and CTL 13 . Impaired movement of lytic granules is also observed in CTL from patients with GSII lacking Rab27a 33 . GSII patients invariably develop HLH within the first 10 years of life 12 . Similar to observations in GSII patients, our patient had complete loss of ex vivo NK cell cytotoxicity, which could partly be restored by stimulation with IL-2 34 . The basis for this compensation is unexplained, but it is possible that perforin-independent pathways contribute. CTL cytotoxicity was also significantly impaired in the absence of AP-3. A previously published comparison of lytic activity of CTL clones derived from HPSII and GSII patients suggested a similar degree of impairment 13 . Unfortunately we did not have access to fresh cells from a non-transplanted GSII patient for a direct comparison. However, the data obtained with the CD107 degranulation assays also suggest that the impariment of CTL degranulation is in a similar range in both disorders. Overall, these immunological data would predict a significant risk of HLH also in patients with HPSII. However, this has not been reported in the three Finally, the observations in our patient suggest that mild facial dysmorphy, dysplasia of the hip, hepatosplenomegaly and developmental delay are also part of this complex clinical syndrome 15, 16 . Although not observed in our young patient, HPSII probably also predisposes to pulmonary fibrosis as reported previously 15, 16 . Some of these features are probably explained by the fact that osteoclast granules and lamellar bodies in pulmonary epithelial cells also belong to the family of lysosome-related organelles 35 . A full definition of HPSII and a better answer to the important question of prognosis and therapy awaits detailed characterization of further patients. With respect to the wide range of organ systems potentially affected by disturbed lysosomal trafficking, it may certainly be anticipated, that more variants of these fascinating disorders will be identified. 
